OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
Keiji Oishi, Kazuto Matsunaga, Toshihiro Shirai, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2670-2670
Open Access | Times Cited: 31
Keiji Oishi, Kazuto Matsunaga, Toshihiro Shirai, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2670-2670
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 8
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 8
Guidance for type 2 inflammatory biomarkers
Kazuto Matsunaga, Akira Koarai, Hiroshi Koto, et al.
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 273-288
Open Access
Kazuto Matsunaga, Akira Koarai, Hiroshi Koto, et al.
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 273-288
Open Access
The Clinical Use of Dupilumab for Elderly Patients with Severe COPD Exacerbations: A Case Series
Hui Cai, Z. Chen, Haiying Ji, et al.
Archivos de Bronconeumología (2025)
Closed Access
Hui Cai, Z. Chen, Haiying Ji, et al.
Archivos de Bronconeumología (2025)
Closed Access
Type 2 Biomarkers and Their Clinical Implications in Bronchiectasis: A Prospective Cohort Study
Yen‐Fu Chen, Hsin‐Han Hou, Ning Chien, et al.
Lung (2024)
Open Access | Times Cited: 3
Yen‐Fu Chen, Hsin‐Han Hou, Ning Chien, et al.
Lung (2024)
Open Access | Times Cited: 3
Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD
Romana Olivia Popețiu, Imola Donath-Miklos, Simona Maria Borta, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6106-6106
Open Access | Times Cited: 7
Romana Olivia Popețiu, Imola Donath-Miklos, Simona Maria Borta, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6106-6106
Open Access | Times Cited: 7
Severe Asthma or Chronic Obstructive Pulmonary Disease with Eosinophilic Inflammation? From Uncertainty to Remission under Anti IL-5R Therapy
Bianca Oprescu, Oana Rădună, Ștefan Mihăicuță, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 387-387
Open Access | Times Cited: 2
Bianca Oprescu, Oana Rădună, Ștefan Mihăicuță, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 387-387
Open Access | Times Cited: 2
Clinical Utility of Central and Peripheral Airway Nitric Oxide in Aging Patients with Stable and Acute Exacerbated Chronic Obstructive Pulmonary Disease
Xiaodong Fan, Nian Zhao, Zhen Yu, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 571-580
Open Access | Times Cited: 16
Xiaodong Fan, Nian Zhao, Zhen Yu, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 571-580
Open Access | Times Cited: 16
Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
Pasquale Ambrosino, Salvatore Fuschillo, Mariasofia Accardo, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1906-1906
Open Access | Times Cited: 11
Pasquale Ambrosino, Salvatore Fuschillo, Mariasofia Accardo, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1906-1906
Open Access | Times Cited: 11
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval
Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 6, pp. 525-536
Closed Access | Times Cited: 6
Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 6, pp. 525-536
Closed Access | Times Cited: 6
Saponins from Aesculus wilsonii seeds exert anti-inflammatory activity through the suppression of NF-κB and NLRP3 pathway
Huimin Li, Huina Cao, Jingya Ruan, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 105077-105077
Open Access | Times Cited: 5
Huimin Li, Huina Cao, Jingya Ruan, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 105077-105077
Open Access | Times Cited: 5
Stepwise management of COPD: What is next after bronchodilation?
Marc Miravitlles, Kazuto Matsunaga, Michael Dreher
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access | Times Cited: 4
Marc Miravitlles, Kazuto Matsunaga, Michael Dreher
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access | Times Cited: 4
The Role of Viral Infections in the Development and Progression of COPD
Robert Burkes
Seminars in Respiratory and Critical Care Medicine (2024)
Closed Access | Times Cited: 1
Robert Burkes
Seminars in Respiratory and Critical Care Medicine (2024)
Closed Access | Times Cited: 1
Periostin as a Biomarker of Allergic Inflammation in Atopic Bronchial Asthma and Allergic Rhinitis (a Pilot Study)
S.V. Krasilnikova, Е.V. Tush, P.A. Frolov, et al.
Sovremennye tehnologii v medicine (2020) Vol. 12, Iss. 5, pp. 37-37
Open Access | Times Cited: 10
S.V. Krasilnikova, Е.V. Tush, P.A. Frolov, et al.
Sovremennye tehnologii v medicine (2020) Vol. 12, Iss. 5, pp. 37-37
Open Access | Times Cited: 10
Practical Recommendations for a Selection of Inhaled Corticosteroids in COPD: A Composite ICO Chart
Keiji Oishi, Kazuto Matsunaga, Tasuku Yamamoto, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 213-213
Open Access | Times Cited: 3
Keiji Oishi, Kazuto Matsunaga, Tasuku Yamamoto, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 213-213
Open Access | Times Cited: 3
From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
Hsu-Hui Wang, Shih-Lung Cheng
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1638-1638
Open Access | Times Cited: 6
Hsu-Hui Wang, Shih-Lung Cheng
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1638-1638
Open Access | Times Cited: 6
Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases
Hoang Oanh Nguyen, Laura Tiberio, Fabrizio Facchinetti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2254-2254
Open Access | Times Cited: 2
Hoang Oanh Nguyen, Laura Tiberio, Fabrizio Facchinetti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2254-2254
Open Access | Times Cited: 2
The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease
Yunhuan Liu, Guanhua Ma, Yan Mou, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2791-2791
Open Access | Times Cited: 4
Yunhuan Liu, Guanhua Ma, Yan Mou, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2791-2791
Open Access | Times Cited: 4
Eosinophilic phenotype was associated with better early clinical remission in elderly patients but not middle‐aged patients with acute exacerbations of COPD
Qianglin Zeng, Hao Wang, Ke Wang, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 9
Open Access | Times Cited: 5
Qianglin Zeng, Hao Wang, Ke Wang, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 9
Open Access | Times Cited: 5
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation
Hoang Oanh Nguyen, Valentina Salvi, Laura Tiberio, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Hoang Oanh Nguyen, Valentina Salvi, Laura Tiberio, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Yiqigubiao pill treatment regulates Sirtuin 5 expression and mitochondrial function in chronic obstructive pulmonary disease
Ting Meng, Feng-Sen Li, Dan Xu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 4, pp. 2326-2340
Open Access
Ting Meng, Feng-Sen Li, Dan Xu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 4, pp. 2326-2340
Open Access
Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis
Qiong Pan, Jiongzhou Sun, Shiyuan Gao, et al.
Archives of Medical Science (2024)
Open Access
Qiong Pan, Jiongzhou Sun, Shiyuan Gao, et al.
Archives of Medical Science (2024)
Open Access
Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells
Hannah Rainer, Alexandra Goretzki, Yen‐Ju Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9914-9914
Open Access
Hannah Rainer, Alexandra Goretzki, Yen‐Ju Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9914-9914
Open Access
Chronic obstructive pulmonary disease's eosinophilic phenotype: Clinical characteristics, biomarkers and biotherapy
Mauro Maniscalco, Claudio Candia, Pasquale Ambrosino, et al.
European Journal of Internal Medicine (2024)
Closed Access
Mauro Maniscalco, Claudio Candia, Pasquale Ambrosino, et al.
European Journal of Internal Medicine (2024)
Closed Access
The Influence of Emphysema on Treatment Response to Biologic Therapy in Severe Asthma
Leonie Biener, Hussein Morobeid, Carmen Pizarro, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1129-1140
Open Access
Leonie Biener, Hussein Morobeid, Carmen Pizarro, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1129-1140
Open Access
[Effects of type 2 inflammation on bronchodilator responsiveness of large and small airways in chronic obstructive pulmonary disease].
Xu Gao, Zhongmiao Gong, Jia-Bin Wang, et al.
PubMed (2024) Vol. 44, Iss. 1, pp. 93-99
Closed Access
Xu Gao, Zhongmiao Gong, Jia-Bin Wang, et al.
PubMed (2024) Vol. 44, Iss. 1, pp. 93-99
Closed Access
